submit to the journals

Atrial fibrillation Journal Articles, Videos And Insights

Atrial fibrillation:FEATURED Articles

flipper_slider

Editor's choice

Atrial fibrillation: Latest Articles

Atrial fibrillation: INSIGHTS

The touchCARDIO website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of cardio:

Insight
Fewer Bleeding Complications with Uninterrupted Dabigatran Versus Warfarin for Ablation in Atrial Fibrillation Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK
Insight
Pacemaker Programme Reduces Dangerous Fainting Episodes in the SPAIN Study Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK
Insight
Left Atrial Appendage Occlusion Reduces Thromboembolism Risk in Patients with Atrial Fibrillation Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK
Insight
Larger Body Size in Women Increases Risk of Atrial Fibrillation Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK
Insight
Heightened Risk of Death for Patients with Atrial Fibrillation Taking Digoxin Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK

Atrial fibrillation:FEATURED VIDEOS

Editor's choice

Dr Purvi Parwani (Assistant Professor of Medicine, Loma Linda University Health, Loma Linda, CA, USA), Professor Mamas Mamas (Professor of Cardiology, University of Keele, Keele, UK) and Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discuss social media in cardiology. Filmed at ESC 2018, Munich. View more content here. Speaker Disclosure: Dr Purvi Parwani, Professor Mamas Mamas and Dr Martha Gulati have nothing to disclose in relation to this video interview. Questions: "How did you get into social media?" (0:41) "How do you think that social media is evolving at conferences?" (1:15) "Social media has been used not only to advocate conferences but it's really changed our profession. There is a huge inequality, for example within women in cardiology - women are finding it increasingly difficult to get positions of leadership. How do you think social media has helped that?" (2.26) "Martha, a while ago you published a really nice paper around myocardial infarction in ladies, and there was a whole Twitter journal club around that. Do you see that's the way, going forwards, in dissemination of academic output?" (3:22) "How do you feel that in terms of education around imaging, social media has helped? (4:40) "How do you see the future of social media [...], how do you see it changing?" (5:25) "Do you see that there's a downside to social media in cardiology?" (6:28 touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Professor Bernard Prendergast (Consultant Cardiologist, London Bridge Hospital, London, UK) discusses percutaneous mitral valve repair and mitral valve regurgitation, with particular emphasis on the results of the MITRA-FR trial and the MitraClip device. Filmed at ESC 2018, Munich. View more content here. Speaker Disclosure: Professor Bernard Prendergast has nothing to disclose in relation to this video interview. Questions: 1. What are the potential advantages and disadvantages of percutaneous mitral valve repair with MitraClip over optimal medical therapy for mitral valve regurgitation? (0:08) 2. What features of the MITRA-FR trial represent an improvement over previous studies assessing percutaneous mitral valve repair as a therapeutic option for mitral valve regurgitation? (1:00) 3. Please summarise the key results of the MITRA-FR trial? (2:02) 4. How do you determine which patients may be suitable for MitraClip? (2:59) 5. What are the short- and long-term goals for the treatment of mitral valve regurgitation? (3:41) 6. How was the study designed? (4:32) touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.

Atrial fibrillation:Latest Videos

Video List based on Category on Node Page

Latest Videos

Dr Purvi Parwani (Assistant Professor of Medicine, Loma Linda University Health, Loma Linda, CA, USA), Professor Mamas Mamas (Professor of Cardiology, University of Keele, Keele, UK) and Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discuss...
Professor Bernard Prendergast (Consultant Cardiologist, London Bridge Hospital, London, UK) discusses percutaneous mitral valve repair and mitral valve regurgitation, with particular emphasis on the results of the MITRA-FR trial and the MitraClip device. Filmed at ESC 2018, Munich. View more...
Tom De Potter (OLV Hospital, Aalst) discusses the aims of recent trials on ultra-low-temperature continuous ablation and summarises the results, which showed that the system is highly efficacious in an acute setting. Although long-term outcomes are yet to be determined, the results so far show...
Joachim Ehrlich (JW Goethe University, Frankfurt) talks about the second-generation balloons used in single-shot cryoablation techniques and their efficacy over older technologies in atrial fibrillation. He also discusses the advantages of cryoablation over radiofrequency ablation; although, as...
Jose Merino (Hospital General Universitario La Paz, Madrid) discusses recent advances in technology to improve complex ablation success rates for atrial fibrillation (AF) and/or ventricular tachycardia (VT), including new imaging techniques, and unmet needs relating to complex ablation for AF/VT,...
Marco Proietti (Institute of Cardiovascular Sciences, University of Birmingham, Birmingham) discusses the SPORTIF Trials and their aim to investigate and compare ximelagatran, the first non-vitamin K antagonist oral anticoagulant, with warfarin in patients with atrial fibrillation. The trial was...

LATEST TWEETS

Conference Highlights